ADC Therapeutics SA

01/07/2021 | Press release | Distributed by Public on 01/07/2021 06:22

ADC Therapeutics Initiates Expanded Access Program for Loncastuximab Tesirine in the U.S.

Read this content
Click here to read the original version at the source's official website. The text of this article is not available at the moment.